M. J. Ackerman, HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, vol.13, issue.8, pp.1308-1339, 2011.
DOI : 10.1093/europace/eur245

N. A. Beard, Calsequestrin and the calcium release channel of skeletal and cardiac muscle, Progress in Biophysics and Molecular Biology, vol.85, issue.1, pp.33-69, 2004.
DOI : 10.1016/j.pbiomolbio.2003.07.001

B. B. Beck, Autosomal Dominant Mutation in the Signal Peptide of Renin in a Kindred With Anemia, Hyperuricemia, and CKD, American Journal of Kidney Diseases, vol.58, issue.5, pp.821-825, 2011.
DOI : 10.1053/j.ajkd.2011.06.029

D. M. Bers, Cardiac excitation???contraction coupling, Nature, vol.415, issue.6868, pp.198-205, 2002.
DOI : 10.1038/415198a

I. Bezprozvanny, Bell-shaped calcium-response curves of lns(l,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum, Nature, vol.351, issue.6329, pp.751-754, 1991.
DOI : 10.1038/351751a0

L. Cartegni, LISTENING TO SILENCE AND UNDERSTANDING NONSENSE: EXONIC MUTATIONS THAT AFFECT SPLICING, Nature Reviews Genetics, vol.3, issue.4, pp.285-298, 2002.
DOI : 10.1038/nrg775

S. R. Chen and D. H. Maclennan, Identification of calmodulin-, Ca(2+)-, and ruthenium red-binding domains in the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum, J Biol Chem, vol.269, issue.36, pp.22698-22704, 1994.

S. De-la-fuente, A Case of Catecholaminergic Polymorphic Ventricular Tachycardia Caused by Two Calsequestrin 2 Mutations, Pacing and Clinical Electrophysiology, vol.91, issue.7, pp.916-919, 2008.
DOI : 10.1111/j.1540-8159.2008.01111.x

M. R. Di-barletta, Clinical Phenotype and Functional Characterization of CASQ2 Mutations Associated With Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation, vol.114, issue.10, pp.1012-1019, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.623793

T. K. Doktor, SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3??? splice site, Human Mutation, vol.89, issue.2, pp.220-230, 2011.
DOI : 10.1002/humu.21419

URL : https://hal.archives-ouvertes.fr/hal-00610797

M. Faggioni, Calsequestrin Mutations and Catecholaminergic Polymorphic Ventricular Tachycardia, Pediatric Cardiology, vol.17, issue.8, pp.959-967, 2012.
DOI : 10.1007/s00246-012-0256-1

M. Faggioni and B. C. Knollmann, Calsequestrin 2 and arrhythmias, AJP: Heart and Circulatory Physiology, vol.302, issue.6, pp.1250-1260, 2012.
DOI : 10.1152/ajpheart.00779.2011

R. E. Green, Widespread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes, Bioinformatics, vol.19, issue.Suppl 1, pp.118-121, 2003.
DOI : 10.1093/bioinformatics/btg1015

W. Guo and K. P. Campbell, Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum, J Biol Chem, vol.270, issue.16, pp.9027-9030, 1995.

I. Gyorke, The Role of Calsequestrin, Triadin, and Junctin in Conferring Cardiac Ryanodine Receptor Responsiveness to Luminal Calcium, Biophysical Journal, vol.86, issue.4, pp.2121-2128, 2004.
DOI : 10.1016/S0006-3495(04)74271-X

M. Hayashi, Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation, vol.119, issue.18, pp.2426-2434, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.829267

URL : https://hal.archives-ouvertes.fr/inserm-00410301

T. D. Houle, Different endoplasmic reticulum trafficking and processing pathways for calsequestrin (CSQ) and epitope-tagged CSQ, Experimental Cell Research, vol.312, issue.20, pp.4150-4161, 2006.
DOI : 10.1016/j.yexcr.2006.09.010

C. Houdayer, Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants, Human Mutation, vol.39, issue.8, pp.1228-1238, 2012.
DOI : 10.1002/humu.22101

S. Huke and D. M. Bers, Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes, Biochemical and Biophysical Research Communications, vol.376, issue.1, pp.80-85, 2008.
DOI : 10.1016/j.bbrc.2008.08.084

S. Hussain, Permanent neonatal diabetes due to a novel insulin signal peptide mutation, Pediatric Diabetes, vol.157, issue.4, pp.299-303, 2013.
DOI : 10.1111/pedi.12011

J. Jabbari, New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia, European Heart Journal, vol.34, issue.suppl 1, pp.481-489, 2013.
DOI : 10.1093/eurheartj/eht308.P2292

H. Jarjanazi, Biological implications of SNPs in signal peptide domains of human proteins, Proteins: Structure, Function, and Bioinformatics, vol.12, issue.11 Part 1, pp.394-403, 2008.
DOI : 10.1002/prot.21548

D. Jiang, RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR), Proceedings of the National Academy of Sciences, vol.101, issue.35, pp.13062-13067, 2004.
DOI : 10.1073/pnas.0402388101

A. Kalyanasundaram, Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background, AJP: Heart and Circulatory Physiology, vol.302, issue.1, pp.253-261, 2012.
DOI : 10.1152/ajpheart.00578.2011

E. Kim, Characterization of Human Cardiac Calsequestrin and its Deleterious Mutants, Journal of Molecular Biology, vol.373, issue.4, pp.1047-1057, 2007.
DOI : 10.1016/j.jmb.2007.08.055

U. Kirchhefer, The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling, Journal of Molecular and Cellular Cardiology, vol.49, issue.1, pp.95-105, 2010.
DOI : 10.1016/j.yjmcc.2010.03.006

Y. M. Kobayashi, Localization and Characterization of the Calsequestrin-binding Domain of Triadin 1: EVIDENCE FOR A CHARGED ??-STRAND IN MEDIATING THE PROTEIN-PROTEIN INTERACTION, Journal of Biological Chemistry, vol.275, issue.23, pp.17639-17646, 2000.
DOI : 10.1074/jbc.M002091200

G. Kuwajima, Two types of ryanodine receptors in mouse brain: Skeletal muscle type exclusively in Purkinje cells and cardiac muscle type in various neurons, Neuron, vol.9, issue.6, pp.1133-1142, 1992.
DOI : 10.1016/0896-6273(92)90071-K

A. Lacampagne, R??cepteur de la ryanodine et dysfonctionnement myocardique, m??decine/sciences, vol.24, issue.4, pp.399-405, 2008.
DOI : 10.1051/medsci/2008244399

H. Lahat, E. Pras, T. Olender, N. Avidan, E. Ben-asher et al., A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel, The American Journal of Human Genetics, vol.69, issue.6, pp.1378-1384, 2001.
DOI : 10.1086/324565

J. T. Lanner, Ryanodine Receptors: Structure, Expression, Molecular Details, and Function in Calcium Release, Cold Spring Harbor Perspectives in Biology, vol.2, issue.11, p.3996, 2010.
DOI : 10.1101/cshperspect.a003996

A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D. Dongoc et al., Catecholaminergic Polymorphic Ventricular Tachycardia in Children : A 7-Year Follow-up of 21 Patients, Circulation, vol.91, issue.5, pp.1512-1519, 1995.
DOI : 10.1161/01.CIR.91.5.1512

N. Liu, Y. Ruan, and S. G. Priori, Catecholaminergic Polymorphic Ventricular Tachycardia, Progress in Cardiovascular Diseases, vol.51, issue.1, pp.23-30, 2008.
DOI : 10.1016/j.pcad.2007.10.005

Q. Q. Liu, C. Oberti, X. Q. Zhang, T. Ke, T. Zhang et al., [A Novel mutation of F189L, CASQ2 in families with catecholaminergic polymorphic ventricular tachycardia]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, pp.334-337, 2008.

N. Lopez-bigas, Are splicing mutations the most frequent cause of hereditary disease?, FEBS Letters, vol.19, issue.9, pp.1900-1903, 2005.
DOI : 10.1016/j.febslet.2005.02.047

URL : https://hal.archives-ouvertes.fr/ensl-00175527

M. Mencarelli, A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity, European Journal of Human Genetics, vol.277, issue.12, pp.1290-1294, 2012.
DOI : 10.1517/13543784.2010.535515

M. L. Milstein, Calsequestrin isoforms localize to different ER subcompartments: Evidence for polymer and heteropolymer-dependent localization, Experimental Cell Research, vol.315, issue.3, pp.523-534, 2009.
DOI : 10.1016/j.yexcr.2008.11.006

R. M. Murphy, Quantification of calsequestrin 2 (CSQ2) in sheep cardiac muscle and Ca2+-binding protein changes in CSQ2 knockout mice, AJP: Heart and Circulatory Physiology, vol.300, issue.2, pp.595-604, 2011.
DOI : 10.1152/ajpheart.00902.2010

J. Nakai, Primary structure and functional expression from cDN A of the cardiac ryanodine receptor/calcium release channel, FEBS Letters, vol.70, issue.1-2, pp.169-177, 1990.
DOI : 10.1016/0014-5793(90)80399-4

C. B. Neylon, S. M. Richards, M. A. Larsen, A. Agrotis, and A. Bobik, Multiple Types of Ryanodine Receptor/Ca2+ Release Channels Are Expressed in Vascular Smooth Muscle, Biochemical and Biophysical Research Communications, vol.215, issue.3, pp.814-821, 1995.
DOI : 10.1006/bbrc.1995.2536

M. Nyegaard, Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death, The American Journal of Human Genetics, vol.91, issue.4, pp.703-712, 2012.
DOI : 10.1016/j.ajhg.2012.08.015

H. Park, S. Wu, A. K. Dunker, and C. Kang, Polymerization of Calsequestrin: IMPLICATIONS FOR Ca2+ REGULATION, Journal of Biological Chemistry, vol.278, issue.18, pp.16176-16182, 2003.
DOI : 10.1074/jbc.M300120200

A. V. Postma, I. Denjoy, T. M. Hoorntje, J. M. Lupoglazoff, A. Da-costa et al., Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation Research, vol.91, issue.8, pp.21-26, 2002.
DOI : 10.1161/01.RES.0000038886.18992.6B

S. G. Priori, C. Napolitano, M. Memmi, B. Colombi, F. Drago et al., Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation, vol.106, issue.1, pp.69-74, 2002.
DOI : 10.1161/01.CIR.0000020013.73106.D8

N. Roux-buisson, J. Rendu, I. Denjoy, P. Guicheney, A. Goldenberg et al., Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management, Human Mutation, vol.358, issue.9, 2011.
DOI : 10.1002/humu.21537

URL : https://hal.archives-ouvertes.fr/inserm-00644146

N. Roux-buisson, Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human, Human Molecular Genetics, vol.21, issue.12, pp.2759-2767, 2012.
DOI : 10.1093/hmg/dds104

URL : https://hal.archives-ouvertes.fr/inserm-00763211

E. J. Sanchez, G. R. Munske, A. Criswell, H. Milting, A. K. Dunker et al., Phosphorylation of human calsequestrin: implications for calcium regulation, Molecular and Cellular Biochemistry, vol.45, issue.3, pp.195-204, 2011.
DOI : 10.1007/s11010-011-0787-4

A. L. Schafer, Panostotic Expansile Bone Disease With Massive Jaw Tumor Formation and a Novel Mutation in the Signal Peptide of RANK, Journal of Bone and Mineral Research, vol.28, issue.4, 2013.
DOI : 10.1002/jbmr.2094

C. Schweingruber, Nonsense-mediated mRNA decay ??? Mechanisms of substrate mRNA recognition and degradation in mammalian cells, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1829, issue.6-7, pp.6-7, 2013.
DOI : 10.1016/j.bbagrm.2013.02.005

X. Shen, C. Franzini-armstrong, J. R. Lopez, L. R. Jones, Y. M. Kobayashi et al., Triadins Modulate Intracellular Ca2+ Homeostasis but Are Not Essential for Excitation-Contraction Coupling in Skeletal Muscle, Journal of Biological Chemistry, vol.282, issue.52, pp.37864-37874, 2007.
DOI : 10.1074/jbc.M705702200

D. W. Shin, J. Ma, K. , and D. H. , and interacts with triadin, FEBS Letters, vol.277, issue.2, pp.178-182, 2000.
DOI : 10.1016/S0014-5793(00)02246-8

D. Terentyev, S. E. Cala, T. D. Houle, S. Viatchenko-karpinski, I. Gyorke et al., Triadin Overexpression Stimulates Excitation-Contraction Coupling and Increases Predisposition to Cellular Arrhythmia in Cardiac Myocytes, Circulation Research, vol.96, issue.6, pp.651-658, 2005.
DOI : 10.1161/01.RES.0000160609.98948.25

D. J. Tester, Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing, Heart Rhythm, vol.3, issue.7, pp.800-805, 2006.
DOI : 10.1016/j.hrthm.2006.03.025

J. A. Towbin, New Revelations about the Long-QT Syndrome, New England Journal of Medicine, vol.333, issue.6, pp.384-385, 1995.
DOI : 10.1056/NEJM199508103330613

M. Vukcevic, Functional Properties of RYR1 Mutations Identified in Swedish Patients with Malignant Hyperthermia and Central Core Disease, Anesthesia & Analgesia, vol.111, issue.1, pp.185-190, 2010.
DOI : 10.1213/ANE.0b013e3181cbd815

H. Watanabe, N. Chopra, D. Laver, H. S. Hwang, S. S. Davies et al., Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans, Nature Medicine, vol.91, issue.4, pp.380-383, 2009.
DOI : 10.1038/nm.1942

A. A. Wilde, Z. A. Bhuiyan, L. Crotti, M. Facchini, G. M. De-ferrari et al., Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia, New England Journal of Medicine, vol.358, issue.19, pp.2024-2029, 2008.
DOI : 10.1056/NEJMoa0708006

S. D. Wilton and S. Fletcher, RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes, Current Gene Therapy, vol.5, issue.5, pp.467-483, 2005.
DOI : 10.2174/156652305774329249